Highlight: The 5th International Symposium on Kallikreins and Kallikrein-Related Peptidases

Articles in the same Issue

1. Frontmatter
2. Guest Editorial
3. Highlight: The 5th International Symposium on Kallikreins and Kallikrein-Related Peptidases
4. KLKs and their hormone-like signaling actions: a new life for the PSA-KLK family
5. Putative kallikrein substrates and their (patho)biological functions
6. Netherton syndrome: defective kallikrein inhibition in the skin leads to skin inflammation and allergy
7. Sweetened kallikrein-related peptidases (KLKs): glycan trees as potential regulators of activation and activity
8. Activation of membrane-bound proteins and receptor systems: a link between tissue kallikrein and the KLK-related peptidases
9. Kallikreins are involved in an miRNA network that contributes to prostate cancer progression
10. Evolution of Klk4 and enamel maturation in eutherians
11. Growth and survival of lung cancer cells: regulation by kallikrein-related peptidase 6 via activation of proteinase-activated receptor 2 and the epidermal growth factor receptor
12. CrataBL, a lectin and Factor Xa inhibitor, plays a role in blood coagulation and impairs thrombus formation
13. Mining for single nucleotide variants (SNVs) at the kallikrein locus with predicted functional consequences
14. Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma
15. Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response
16. Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer
17. Prognostic significance of human tissue kallikrein-related peptidases 6 and 10 in gastric cancer
18. Loss of miR-378 in prostate cancer, a common regulator of KLK2 and KLK4, correlates with aggressive disease phenotype and predicts the short-term relapse of the patients
19. Kallikrein-related peptidase 6 (KLK6) expression in the progression of colon adenoma to carcinoma
20. Development of monoclonal antibodies to human kallikrein-related peptidase 6 (KLK6) and their use in an immunofluorometric assay for free KLK6
21. Analysis of androgen and anti-androgen regulation of KLK-related peptidase 2, 3, and 4 alternative transcripts in prostate cancer